Latest news
Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients - WSJWSJ · Mon, 10 Aug 2026 06:04:46 GMTAs companies in America face rising health costs, Starbucks ends employee benefits' coverage for these me - The Times of IndiaThe Times of India · Mon, 10 Aug 2026 02:59:00 GMTEli Lilly (NYSE: LLY) Files For Next-Gen Weight-Loss Drug Retatrutide In Q1 2027, Leaving Novo Nordisk (NYSE: NVO) Scrambling - foreignpolicyjournal.comforeignpolicyjournal.com · Mon, 10 Aug 2026 00:24:00 GMT‘Ozempic Butt’ Isn’t Always Muscle Loss—What Experts Want Patients To Know - NewsweekNewsweek · Sun, 09 Aug 2026 14:00:00 GMTExperts Are Explaining The Real Reason Some GLP-1 Users Lose Hair - Yahoo Lifestyle CanadaYahoo Lifestyle Canada · Sat, 08 Aug 2026 16:16:02 GMTMemorial doctor discusses benefits, risks of GLP-1 weight loss medications - WLOXWLOX · Sat, 08 Aug 2026 13:44:00 GMTEli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - finance.yahoo.comfinance.yahoo.com · Fri, 07 Aug 2026 22:50:00 GMTStarbucks is ending GLP-1 coverage for weight loss as employer costs climb - Business InsiderBusiness Insider · Fri, 07 Aug 2026 20:41:00 GMT